(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALLEGRA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ALLEGRA

ST13

US500000098309897

Class

5

Filing

98309897

Registration

7893195

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

08/12/2025

Trademark type

Combined

Nice classes

5

Filing date

12/12/2023

Registration date

08/12/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/12/2025

Last transaction

08/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/01/2024

First use in commerce

01/01/2024

Drawing code

3

Owner type

16

Owner location

Bridgewater, NJ, US

Examiner

SALTZMAN,DANIEL R

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "ALLEGRA" in white lettering with an orange, yellow, white and purple colored arrow over the last letter "A" in "ALLEGRA," all on a purple background. The arrow has four purple rays projecting away from it in a direction opposite to the way the arrow points.

Holders and representatives

Holders

Aventisub LLC

Representatives

Jonathan M. Rixen Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of allergic conditions and respiratory diseasesnot for ophthalmic use; nutritional supplements; food supplements for medical use.

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/12/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/12/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/24/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/24/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

07/24/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/24/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

07/24/2025

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

07/24/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/22/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/22/2025

IUAF

USE AMENDMENT FILED

04/07/2025

EISU

TEAS STATEMENT OF USE RECEIVED

04/07/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/19/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/19/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/19/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/19/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/15/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/20/2024

PUBO

PUBLISHED FOR OPPOSITION

08/20/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/31/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/15/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

07/15/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/15/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

07/15/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/15/2024

DOCK

ASSIGNED TO EXAMINER

07/11/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/14/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/14/2024

NWAP

NEW APPLICATION ENTERED

12/12/2023

Continuous trademark protection

Get notified about every new filing that threatens ALLEGRA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.